nicotine has been researched along with sch 23390 in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 20 (95.24) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
Bevins, RA; Carroll, FI; Wilkinson, JL | 1 |
Hashim, A; Lajtha, A; Sershen, H | 1 |
Booth, S; Caggiula, AR; Gharib, M; Jernigen, C; Liu, X; Sved, AF | 1 |
Asadi, F; Bahrami, F; Naghdi-Sedeh, N; Nasehi, M; Sahraei, H; Zarrindast, MR | 1 |
Bardo, MT; Neugebauer, NM; Stairs, DJ | 1 |
Mafi, F; Nasehi, M; Nasri, S; Oryan, S; Zarrindast, MR | 1 |
Ahmadi, S; Azizbeigi, R; Babapour, V; Rezayof, A; Zarrindast, MR | 1 |
Duchemin, AM; Hadjiconstantinou, M; McCarthy, MJ; Neff, NH | 1 |
Eslahi, N; Rezayof, A; Rostami, P; Zahmatkesh, M; Zarrindast, MR | 1 |
Burke, D; Hall, BJ; Kutlu, MG; Levin, ED; Rose, JE; Slade, S | 1 |
Akins, CK; Levi Bolin, B; Singleton, DL | 1 |
Fletcher, PJ; Guy, EG | 1 |
Brianna Sheppard, A; Brown, RW; Kellicut, MR; Palmatier, MI; Robinson, DL | 1 |
Bergstrom, HC; Burke, JC; Ehlinger, DG; Fernandez, GM; McDonald, CG; Smith, RF | 1 |
Goutier, W; Lowry, JP; McCreary, AC; O'Connor, JJ | 2 |
Allenby, C; Hall, BJ; Kutlu, MG; Levin, ED; Slade, S | 1 |
Ghasemzadeh, Z; Keshavarzian, E; Rezayof, A | 1 |
DiPalma, D; Evans, J; Hall, BJ; Howard, S; Levin, ED; McMillan, C; Nangia, A; Rezvani, AH; Slade, S; Tharwani, S; Wells, C; Willette, BKA | 1 |
Balachandran, RC; Eubig, PA; Hatcher, KM; Mahoney, MM; Molina, LM; Sieg, ML; Sullivan, EK | 1 |
21 other study(ies) available for nicotine and sch 23390
Article | Year |
---|---|
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bupropion; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2010 |
Differences between nicotine and cocaine-induced conditioned place preferences.
Topics: Adrenergic alpha-Antagonists; Animals; Atropine; Benzazepines; Cocaine; Conditioning, Classical; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phentolamine; Space Perception | 2010 |
Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats.
Topics: Animals; Behavior, Addictive; Benzazepines; Conditioning, Operant; Cues; Dopamine Antagonists; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Nicotine; Rats; Rats, Sprague-Dawley; Salicylamides; Secondary Prevention; Self Administration | 2010 |
The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response.
Topics: Animals; Anxiety; Apomorphine; Benzazepines; Dopamine Agents; Dopamine D2 Receptor Antagonists; Hippocampus; Male; Maze Learning; Motor Activity; Nicotine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2010 |
Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats.
Topics: Anesthetics, Local; Animals; Behavior, Animal; Benzazepines; Cocaine; Conditioning, Operant; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Extinction, Psychological; Food Preferences; Infusions, Intravenous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Sucrose | 2010 |
The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response.
Topics: Animals; Anxiety; Behavior, Animal; Benzazepines; Dopamine Agents; Hippocampus; Male; Mice; Nicotine | 2011 |
Nicotine restores morphine-induced memory deficit through the D1 and D2 dopamine receptor mechanisms in the nucleus accumbens.
Topics: Animals; Avoidance Learning; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Memory Disorders; Morphine; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 2011 |
CREB involvement in the regulation of striatal prodynorphin by nicotine.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Corpus Striatum; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Dynorphins; Enkephalins; Male; Mecamylamine; Mice; Nicotine; Phosphorylation; Protein Binding; Protein Precursors; Response Elements; Time Factors; Transcription, Genetic | 2012 |
Modulation of ventral tegmental area dopamine receptors inhibit nicotine-induced anxiogenic-like behavior in the central amygdala.
Topics: Amygdala; Animals; Anxiety; Benzazepines; Dopamine Antagonists; Injections, Intraventricular; Male; Nicotine; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Ventral Tegmental Area | 2013 |
Role of insular cortex D₁ and D₂ dopamine receptors in nicotine self-administration in rats.
Topics: Animals; Benzazepines; Cerebral Cortex; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Nicotine; Nicotinic Agonists; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Self Administration; Time Factors; Tobacco Use Disorder | 2013 |
Pavlovian discriminative stimulus effects of methamphetamine in male Japanese quail (Coturnix japonica).
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Cocaine; Conditioning, Classical; Coturnix; Discrimination, Psychological; Female; Generalization, Psychological; Haloperidol; Male; Methamphetamine; Nicotine; Receptors, Dopamine D1; Sexual Behavior, Animal | 2014 |
Responding for a conditioned reinforcer, and its enhancement by nicotine, is blocked by dopamine receptor antagonists and a 5-HT(2C) receptor agonist but not by a 5-HT(2A) receptor antagonist.
Topics: Animals; Benzazepines; Conditioning, Classical; Dopamine Antagonists; Ethylamines; Fluorobenzenes; Indoles; Male; Nicotine; Piperidines; Rats, Long-Evans; Reinforcement, Psychology; Salicylamides; Serotonin 5-HT2 Receptor Antagonists | 2014 |
The incentive amplifying effects of nicotine are reduced by selective and non-selective dopamine antagonists in rats.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Classical; Cues; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flupenthixol; Male; Nicotine; Rats; Reinforcement, Psychology; Salicylamides | 2014 |
Adolescent nicotine-induced dendrite remodeling in the nucleus accumbens is rapid, persistent, and D1-dopamine receptor dependent.
Topics: Animals; Benzazepines; Dendrites; Male; Neuronal Plasticity; Nicotine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2016 |
The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Benzazepines; Colforsin; Cyclic AMP; Dopamine Agents; Dose-Response Relationship, Drug; Electrochemical Techniques; Male; Motor Activity; Nicotine; Nicotinic Agonists; Protein Binding; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine D1; Time Factors; Tritium | 2015 |
Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats.
Topics: Animals; Benzazepines; Brain Mapping; Catheters, Indwelling; Cohort Studies; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Gyrus Cinguli; Haloperidol; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Parietal Lobe; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Self Administration; Tobacco Use Disorder | 2015 |
Frequency-Dependent Modulation of Dopamine Release by Nicotine and Dopamine D1 Receptor Ligands: An In Vitro Fast Cyclic Voltammetry Study in Rat Striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine; Electric Stimulation; In Vitro Techniques; Ligands; Male; Nicotine; Rats, Wistar; Receptors, Dopamine D1 | 2016 |
The basolateral amygdala dopaminergic system contributes to the improving effect of nicotine on stress-induced memory impairment in rats.
Topics: Animals; Apomorphine; Avoidance Learning; Basolateral Nuclear Complex; Benzazepines; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Mental Recall; Microinjections; Nicotine; Rats; Receptors, Dopamine D1; Stress, Psychological; Sulpiride | 2018 |
Acute and chronic interactive treatments of serotonin 5HT
Topics: Animals; Benzazepines; Female; Nicotine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Self Administration; Tobacco Use Disorder | 2019 |
Pharmacological challenges examining the underlying mechanism of altered response inhibition and attention due to circadian disruption in adult Long-Evans rats.
Topics: Animals; Attention; Benzazepines; Choline O-Acetyltransferase; Chronobiology Disorders; Circadian Clocks; Circadian Rhythm; Cognition; Disease Models, Animal; Dopamine Antagonists; Female; Gene Expression; Impulsive Behavior; Male; Nicotine; Nicotinic Agonists; Period Circadian Proteins; Rats; Rats, Long-Evans; Reaction Time; Receptors, Dopamine D1; Salicylamides | 2020 |